- CNXC Dashboard
-
Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Concentrix (CNXC) Financial statements
Company Profile
Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | ||
---|---|---|---|---|---|
Total Revenue | |||||
Cost of Revenue | |||||
Gross Profit | |||||
Gross Profit Margin (%) | |||||
R&D Expense | |||||
SG&A Expense | |||||
Total Operating Expenses | |||||
Operating Income or Loss | |||||
Operating Margin (%) | |||||
Interest Expense | |||||
Total Other Income/Expenses | |||||
Income Before Tax | |||||
Income Tax Expense | |||||
Income from Continuing Ops. | |||||
Net Income | |||||
Net Profit Margin (%) | |||||
Net Income Available to Common Shareholders | |||||
Basic EPS | |||||
Diluted EPS | |||||
Basic Average Shares | |||||
Diluted Average Shares |
Aug 2024 | May 2024 | Feb 2024 | Nov 2023 | Aug 2023 | May 2023 | Feb 2023 | Nov 2022 | Aug 2022 | May 2022 | Feb 2022 | Nov 2021 | Aug 2021 | May 2021 | Feb 2021 | Nov 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | |||||||||||||||||
Cost of Revenue | |||||||||||||||||
Gross Profit | |||||||||||||||||
Gross Profit Margin (%) | |||||||||||||||||
R&D Expense | |||||||||||||||||
SG&A Expense | |||||||||||||||||
Total Operating Expenses | |||||||||||||||||
Operating Income or Loss | |||||||||||||||||
Operating Margin (%) | |||||||||||||||||
Interest Expense | |||||||||||||||||
Total Other Income/Expenses | |||||||||||||||||
Income Before Tax | |||||||||||||||||
Income Tax Expense | |||||||||||||||||
Income from Continuing Ops. | |||||||||||||||||
Net Income | |||||||||||||||||
Net Profit Margin (%) | |||||||||||||||||
Net Income Available to Common Shareholders | |||||||||||||||||
Basic EPS | |||||||||||||||||
Diluted EPS | |||||||||||||||||
Basic Average Shares | |||||||||||||||||
Diluted Average Shares |
Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | ||
---|---|---|---|---|---|
Current Assets | |||||
Cash & Cash Equivalents | |||||
Marketable Securities | |||||
Receivables | |||||
Inventories | |||||
Other Current Assets | |||||
Total Current Assets | |||||
Non-Current Assets | |||||
Marketable Securities | |||||
PPE Net | |||||
Intangibles inc. Goodwill | |||||
Other Non-Current Assets | |||||
Total Non-Current Assets | |||||
Total Assets | |||||
Current Liabilities | |||||
Accounts Payable | |||||
Deferred Revenues | |||||
Debt, Current | |||||
Accrued Liabilities | |||||
Other Current Liabilities | |||||
Total Current Liabilities | |||||
Non-Current Liabilities | |||||
Deferred Revenues | |||||
Debt, Non-Current | |||||
Other Non-Current Liabilities | |||||
Total Non-Current Liabilities | |||||
Total Liabilities | |||||
Shareholders' Equity | |||||
Common Stock | |||||
Additional Paid-In Capital | |||||
Retained Earnings | |||||
Other Shareholders' Equity | |||||
Total Shareholders' Equity | |||||
Total Liabilities & Shareholders' Equity |
Aug 2024 | May 2024 | Feb 2024 | Nov 2023 | Aug 2023 | May 2023 | Feb 2023 | Nov 2022 | Aug 2022 | May 2022 | Feb 2022 | Nov 2021 | Aug 2021 | May 2021 | Feb 2021 | Nov 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Current Assets | |||||||||||||||||
Cash & Cash Equivalents | |||||||||||||||||
Marketable Securities | |||||||||||||||||
Receivables | |||||||||||||||||
Inventories | |||||||||||||||||
Other Current Assets | |||||||||||||||||
Total Current Assets | |||||||||||||||||
Non-Current Assets | |||||||||||||||||
Marketable Securities | |||||||||||||||||
PPE Net | |||||||||||||||||
Intangibles inc. Goodwill | |||||||||||||||||
Other Non-Current Assets | |||||||||||||||||
Total Non-Current Assets | |||||||||||||||||
Total Assets | |||||||||||||||||
Current Liabilities | |||||||||||||||||
Accounts Payable | |||||||||||||||||
Deferred Revenues | |||||||||||||||||
Debt, Current | |||||||||||||||||
Accrued Liabilities | |||||||||||||||||
Other Current Liabilities | |||||||||||||||||
Total Current Liabilities | |||||||||||||||||
Non-Current Liabilities | |||||||||||||||||
Deferred Revenues | |||||||||||||||||
Debt, Non-Current | |||||||||||||||||
Other Non-Current Liabilities | |||||||||||||||||
Total Non-Current Liabilities | |||||||||||||||||
Total Liabilities | |||||||||||||||||
Shareholders' Equity | |||||||||||||||||
Common Stock | |||||||||||||||||
Additional Paid-In Capital | |||||||||||||||||
Retained Earnings | |||||||||||||||||
Other Shareholders' Equity | |||||||||||||||||
Total Shareholders' Equity | |||||||||||||||||
Total Liabilities & Shareholders' Equity |
Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | ||
---|---|---|---|---|---|
Cash Flows from Operating Activities | |||||
Net Income | |||||
Depreciation & Amortization | |||||
Deferred Income Taxes | |||||
Stock Based Compensation | |||||
Accounts Receivable | |||||
Inventory | |||||
Accounts Payable | |||||
Deferred Revenue | |||||
Other Non-Cash | |||||
Operating Cash Flow | |||||
Cash Flows from Investing Activities | |||||
PPE Investments | |||||
Net Acquisitions | |||||
Purchase of Investments | |||||
Sale of Investments | |||||
Other Investing Activity | |||||
Investing Cash Flow | |||||
Cash Flows from Financing Activities | |||||
Debt Issued | |||||
Proceeds from Debt Repayment | |||||
Debt Repayment | |||||
Proceeds from Sale of Equity | |||||
Equity Repurchased | |||||
Dividend Paid | |||||
Other Financing Activity | |||||
Financing Cash Flow | |||||
Cash Position | |||||
Beginning Cash Position | |||||
End Cash Position | |||||
Change in Cash | |||||
Free Cash Flow | |||||
Operating Cash Flow | |||||
Capital Expenditure | |||||
Free Cash Flow |
Aug 2024 | May 2024 | Feb 2024 | Nov 2023 | Aug 2023 | May 2023 | Feb 2023 | Nov 2022 | Aug 2022 | May 2022 | Feb 2022 | Nov 2021 | Aug 2021 | May 2021 | Feb 2021 | Nov 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | |||||||||||||||||
Net Income | |||||||||||||||||
Depreciation & Amortization | |||||||||||||||||
Deferred Income Taxes | |||||||||||||||||
Stock Based Compensation | |||||||||||||||||
Accounts Receivable | |||||||||||||||||
Inventory | |||||||||||||||||
Accounts Payable | |||||||||||||||||
Deferred Revenue | |||||||||||||||||
Other Non-Cash | |||||||||||||||||
Operating Cash Flow | |||||||||||||||||
Cash Flows from Investing Activities | |||||||||||||||||
PPE Investments | |||||||||||||||||
Net Acquisitions | |||||||||||||||||
Purchase of Investments | |||||||||||||||||
Sale of Investments | |||||||||||||||||
Other Investing Activity | |||||||||||||||||
Investing Cash Flow | |||||||||||||||||
Cash Flows from Financing Activities | |||||||||||||||||
Debt Issued | |||||||||||||||||
Proceeds from Debt Repayment | |||||||||||||||||
Debt Repayment | |||||||||||||||||
Proceeds from Sale of Equity | |||||||||||||||||
Equity Repurchased | |||||||||||||||||
Dividend Paid | |||||||||||||||||
Other Financing Activity | |||||||||||||||||
Financing Cash Flow | |||||||||||||||||
Cash Position | |||||||||||||||||
Beginning Cash Position | |||||||||||||||||
End Cash Position | |||||||||||||||||
Change in Cash | |||||||||||||||||
Free Cash Flow | |||||||||||||||||
Operating Cash Flow | |||||||||||||||||
Capital Expenditure | |||||||||||||||||
Free Cash Flow |